Supplemental material
Current Medical Research and Opinion
Volume 37, 2021 - Issue 11
Publishing
Open Pharma recommendations for plain language summaries of peer-reviewed medical journal publications
Adeline Rosenberga Oxford PharmaGenesis Ltd, Oxford, UKCorrespondence[email protected]
https://orcid.org/0000-0003-4599-4291
https://orcid.org/0000-0003-4599-4291, Slávka Barónikováb Galápagos NV, Mechelen, Belgiumhttps://orcid.org/0000-0001-8072-5690
https://orcid.org/0000-0001-8072-5690, Linda Feigheryc UCB Pharma, Slough, UKhttps://orcid.org/0000-0001-9396-0227
https://orcid.org/0000-0001-9396-0227, William Gattrelld Ipsen, Milton Park, UKhttps://orcid.org/0000-0002-9733-6330
https://orcid.org/0000-0002-9733-6330, Rikke Egelund Olsene F. Hoffmann-La Roche Ltd, Basel, Switzerlandhttps://orcid.org/0000-0002-3261-3886
https://orcid.org/0000-0002-3261-3886, Adam Watsonf Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0002-5707-0523
https://orcid.org/0000-0002-5707-0523, Tim Kodera Oxford PharmaGenesis Ltd, Oxford, UKhttps://orcid.org/0000-0001-6152-7365
https://orcid.org/0000-0001-6152-7365 & Christopher Winchestera Oxford PharmaGenesis Ltd, Oxford, UKhttps://orcid.org/0000-0003-3267-3990
https://orcid.org/0000-0003-3267-3990 show allRelated Research Data
Open Pharma recommendations for plain language summaries of peer-reviewed medical journal publications
Source:
Taylor & Francis
Open Pharma recommendations for plain language summaries of peer-reviewed medical journal publications
Source:
Taylor & Francis
Open Pharma recommendations for plain language summaries of peer-reviewed medical journal publications
Source:
Taylor & Francis
Linking provided by
